Dichloroacetate and cerebral ischaemia therapeutics

Bibliography

• MELDRUM B, FEUERSTEIN G, HUNTER J, BARONE FC,VON LUBITZ DKJE, MARANGOS PJ: (7) Excitatory amino acids and neuroprotection; (8) Calcium channel blockers & neuroprotection; (9) Self-defense of the brain: adenosinergic strategies in neurodegeneration. In: Emerging Strategies in Neuroprotection. Marangos PJ, La! H (Eds.), Birkhauser, Boston, USA (1992):106–186.
   Google Scholar
• SIESJO BK: Acidosis and ischemic brain damage. Neuro-chem. Pathol (1998) 9:31–88.
   Google Scholar
• REHNCRONA S, ROSEN I, SEISJO BK: Brain lactic acidosisand ischemic cell damage 1. Biochemistry and neuro-physiology. J. Cerebral Blood Flow Metab. (1981) 1(3):297–311.
   PubMed Web of Science ®Google Scholar
• ESPINAL J, LEESNITZER T, HASSMAN A, BEGGS M, COBB J:Inhibition of pyruvate dehydrogenase kinase by halogenated acetophenones. Drug Dev. Res. (1995) 35:130–136.
   Web of Science ®Google Scholar
• FOX AW, YANG X, MURLI H, LAWLOR TE, CIFONE MA, RENO FE: Absence of mutagenic effects of sodium di-chloroacetate. Fund. Appl. Toxicol (1996) 32:87–95.
   PubMedGoogle Scholar
• WASKELL L et al.: A study of the mutagenicity of anes-thetics and their metabolites. Mutat. Res. (1978) 57:141–153.
   PubMed Web of Science ®Google Scholar
• MATSUDA et al.: Mutagenicity of ozonation and chlori-nation products from p-hydroxbenzaldehyde. Sci. Tot. Environ. (1991) 103:141–149.
   PubMed Web of Science ®Google Scholar
• HERBERT et al.: Mutagenicity of DCA, an ingredient ofsome formulations of pangamic acid. Am. J. Clin. Nutr. (1980) 33:1179–1182.
   PubMed Web of Science ®Google Scholar
• WHITEHOUSE S, RANDLE PJ: Activation of pyruvate de-hydrogenase in perfused rat heart by dichloroacetate. Biochem. J. (1973) 134:651–653.
   PubMed Web of Science ®Google Scholar
• WHITEHOUSE S, COOPER RH, RANDLE PH: Mechanismof activation of pyruvate dehydrogenase by dichloroa-cetate and other halogenated carboxylic acids. Bio-chem. J. (1974) 141:761–774.
   PubMed Web of Science ®Google Scholar
• ABEMAYOR E, KOVACHICH GB, HAUGAARD H: Effectsof dichloroacetate on brain pyruvate dehydrogenase. Neurochem. (1984) 42(1)38–42.
   Google Scholar
• STACPOOLE PW: The pharmacology of dichloroace-tate. Metabolism (1989) 38(10:1124–1144.
   PubMedGoogle Scholar
• SCH'DER H, KNIGHT RJ, KOFOED KF, SCHELBERT HR, BUXTON DB: Regulation of pyruvate dehydrogenase activity and glucose metabolism in post-ischaemic myocardium. Biochem. Biophys. Acta. (1998) 1406:62–72.
   PubMed Web of Science ®Google Scholar
• OKABE I, KODAMA H, SHIMOIZUMI H, KAMOSHITA S,MIYABAYASHI S: Treatment of lactic acidosis: effects of dichloroacetate on lactate and pyruvate levels in the cerebrospinal fluid. Eur. J. Pediatr. (1986) 145:159.
   PubMed Web of Science ®Google Scholar
• DIMLICH RV, BIROS MH, BARSAN WG: Treatment of lac-tic acidosis that follows partial global ischemia in the rat. J. Cerebral. Blood Flow Metab. (1985) 5(1):S237–S238.
   Google Scholar
• COLOHAN AR, WELSH FA, MILLER ED, KASSELL NF: Theeffect of dichloroacetate on brain lactate levels follow-ing incomplete ischemia in the hyperglycemic rat. Stroke (1986) 17(3):525–528.
   PubMed Web of Science ®Google Scholar
• DIMLICH RV, NIELSEN MM: Facilitating post-ischemicreduction of cerebral lactate in rats. Stroke (1992) 23 (8):1145–1152.
   PubMed Web of Science ®Google Scholar
• SMITH ML, VON HANWEHR R, SIESJO BK: Changes inextra-and intracellular pH in the brain during and fol-lowing ischemia in hyperglycemic and in moderately hypoglycemic rats. J. Cerebral Blood Flow Metab. (1986) 6:574–583.
   PubMed Web of Science ®Google Scholar
• WOLFE RR, JAHOOR F, HERNDON DN, MIYOSHI H: Iso-topic evaluation of the metabolism of pyruvate and re-lated substrates in normal adult volunteers and severely burned children: effect of dichloroacetate and glucose infusion. Surgmy (1991) 110(1):54–67.
   PubMed Web of Science ®Google Scholar
• KALIMO H, RECHCRONA S, SODERFELDT B, OLSSON Y, SIESJO BK: Brain lactic acidosis and ischemic cell dam-age: 2 Histopathology. J. Cerebral Blood Flow Metab. (1981) 1(3):313–327.
   PubMed Web of Science ®Google Scholar
• DESALLES AAF, KONTOS HA, BECKER DP et al.: Prognos-tic significance of ventricular CSF lactic acidosis in se-vere head injury. J. Neurosurg. (1986) 65:615–624.
   PubMed Web of Science ®Google Scholar
• CROCKARD HA, TAYLOR AR: Serial CSF lactate/pyruvate values as a guide to prognosis in head injury coma. Cerebral Blood Flow and Intra cranial Pressure. Proc. 5th In-ternational Symposium. Rome-Sienna, Italy. (1971) :151–157.
   Google Scholar
• MARMAROU A, HOLDAWAY R, WARD JD et al: Traumatic brain tissue acidosis: experimental and clinical stud-ies. Acta. Neurochir. (1993) 57:160–164.
   Google Scholar
• CORBETT R, LAPTOOK A, GEE J, GARCIA D, SILMON S,TOLLEFSBOL G: Age-related differences in the effect of dichloroacetate on postischemic lactate and acid clear-ance measured in vivousing magnetic resonance spec-troscopy and microdialysis. J. Neurochem. (1998) 71 (3):1205–1214.
   PubMed Web of Science ®Google Scholar
• CHANG LH, SHIMIZU H, ABIKO H eta].: Effect of dicholo-roacetate on recovery of brain lactate, phosphorus en-ergy metabolites, and glutamate during reperfusion after complete cerebral ischemia in rats. J. Cerebral Blood Flow Metab. (1992) 12 (6) :1030–1038.
   Google Scholar
• BIROS MH, DIMLICH RVW: Brain lactate during partial global ischemia and reperfusion. Am. J. Emerg. Med. (1987) 5(4):271–277.
   PubMed Web of Science ®Google Scholar
• BIROS MH, DIMLICH RV, BARSAN WG: Post-insult treat-ment of ischemia induced cerebral lactic acidosis in the rat. Am. J. Emerg. Med. (1986) 15 (4) :397–404.
   Google Scholar
• TOMSIG JL, GRUENSTEIN E, DIMLICH RVW: Inhibition of lactate induced swelling by dichloroacetate in human astrocytoma cells. Brain Res. (1991) 568:92–100.
   PubMed Web of Science ®Google Scholar
• BIROS MH, ZINK J: Dichloroacetate and hyperbaric oxygenation treatment of post-traumatic cerebral edema in rats. Am. J. Emerg. Med. (1991) 20(4):478–479.
   Google Scholar
• BIROS MH, NORDNESS R: Effect of chemical interven-tions on cerebral edema formation after head trauma in rats. Am. J. Emerg. Med. (1989) 18:477.
   Google Scholar
• BIROS MH, NORDNESS R: Effect of chemical pretreat-ment on posttraumatic cortical edema in rat. Am. J. Emerg. Med. (1996) 14:27:32.
   Google Scholar
• ROBERTSON CS, GOODMAN JC, GROSSMAN RG, PRIESS-MAN A: Reduction in spinal cord post-ischemic lactic acidosis and functional improvement with dichloroa-cetate. j Neurotraum. (1990) 7 (1) :1–12.
   PubMed Web of Science ®Google Scholar
• BARSAN WG, HEDGES JR, SYVERUD SA, DRONEN SC,DIMLICH RVW: Effects of dichloroacetate in spinal stroke in the rabbit. Life Sci. (1987) 41:1065–1069.
   PubMedGoogle Scholar
• DIMLICH RVW, MARANGOS PJ: Dichloroacetate attenu-ates neuronal damage in a gerbil model of brain ische-mia. j Mol Neurosci. (1994) 5:69–81.
   PubMed Web of Science ®Google Scholar
• KATAYAMA Y, WELSH FA: Effect of dichloroacetate onregional energy metabolites and pyruvate dehydrogenase activity during ischemia and reperfusion in gerbil brain. J. Neurochem. (1989) 52 (6) 1817–1822
   PubMed Web of Science ®Google Scholar
• CYPROS PHARMACEUTICAL CORPORATION: DCA re-duces cerebral infarct volume following transient cerebral ischemia in rats (Cypros report #21102). (1993) :1–2 (Unpublished).
   Google Scholar
• HU CL: Treatment of experimental ischemic cerebrallactic acidosis in rats with dichloroacetate. Chin. Neu-rol. Psych. J. (1992) 25:355–357.
   Google Scholar
• PEELING J, SUTHERLAND G, BROWN RA, CURRY S: Pro-tective effect of dichloroacetate in a rat model of fore-brain ischemia. Neurosci. Lett. (1996) 208:21–24.
   PubMed Web of Science ®Google Scholar
• KATZ R, TAI CN, DIENER RM, MCCONNELL RF, SEMONICKDE: Dichloroacetate, sodium 3 month oral toxicity studies in rats and dogs. Tox. Appl. Pharmacol. (1981) 57:273–287.
   PubMed Web of Science ®Google Scholar
• CYPROS PHARMACEUTICAL CORP: Internal study re-ports. (Jan. 1999). (Unpublished).
   Google Scholar
• YOUNT EA, FELTEN SY, O'CONNOR BL et al.: Compari-son of the metabolic and toxic effects of 2-chloropropionate and dichloroacetate. J. Pharmacol Exp. Ther. (1982) 222 (2) :501–508.
   Google Scholar
• WOODARD G, LANGE SW, NELSON KW, CALVERY HO:The acute oral toxicity of acetic, chloroacetic, dichlo-roacetic and trichloroacetic acids. J. Indust. Hyg. Tox. (1941) 23:78–82.
   Google Scholar
• CURRY SH, CHU PI, BAUMGARTNER TG, STACPOOLE PW:Plasma concentrations and metabolic effects of intra-venous sodium dichloroacetate. Clin. Pharm. Ther. (1985) 37:89–93.
   PubMed Web of Science ®Google Scholar
• STACPOOLE PW, HENDERSON GN, YAN Z, CORNETT RJAMES MO: Pharmacokinetics, metabolism, and toxi-cology of dichloroacetate. Drug Metab. Rev. (1998) 30(3) 499–539.
   PubMed Web of Science ®Google Scholar
• JAMES MO, CORNETT R, YAN Z, HENDERSON GN STACPOOLE PW: Glutathione-dependent conversion to glyoxylate, a major pathway of dichloroacetate bio-transformation in hepatic cytosol from humans and rats, is reduced in dichloroacetate-treated rats. Drug Metab. Disp. (1997) 25:11.
   Google Scholar
• KATZ R, TAI CN, DIENER RM, MCCONNELL RF, SEMONICKDE: Dichloroacetate, sodium 3 month oral toxicity studies in rats and dogs. Tox. Appl. Pharmacol. (1981) 57:274–287.
   Google Scholar
• CICMANEC JLA, CONDIE LW, OLSON GR, WANG SR: 90 Day toxicity study of dichloroacetate in dogs. Fund. Appl. Tox. (1991) 17:376–389.
   PubMedGoogle Scholar
• MATHER GG, EXON JH, KOLLER LD: Subchronic 90 day toxicity of dichloroacetate and trichloroacetate acid in rats. Toxicology (1990) 64:71–80.
   PubMed Web of Science ®Google Scholar
• CURRY SH, LORENZ A, CHU PI, LIMACHER M, STACPOOLEPW: Disposition and pharmacodynamics of dichloroa-cetate (DCA) and oxalate following oral DCA doses. Biopharm. Drug Disp. (1991) 12:375–390.
   PubMed Web of Science ®Google Scholar
• LUKAS G, VYAS KH, BRINDLE SD, LESHER AR, WAGNER WE: Biological disposition of sodium dichloroacetate in animals and humans after intravenous administra-tion. J. Pharma. ScL (1980) 69 (4) :419–421.
   PubMed Web of Science ®Google Scholar
• WELLS PG, MOORE GW, RABIN D, WILKINSON GR, OATES JA, STACPOOLE PW: Metabolic effects and phar-macokinetics of intravenously administered dichlo-roacetate in humans. Diablogia (1980) 19:109–113.
   PubMed Web of Science ®Google Scholar
• FOX AW, SULLIVAN BW, BUFFINI et al.: Reduction of se-rum lactate by sodium dichloroacetate, and human pharmacokinetic-pharmacodynamic relationships. J. Pharmacol. Exp. Ther. (1996) 279:686–693.
   PubMed Web of Science ®Google Scholar
• SAITOH S, MOMOI MY, YAMAGATA T, MORE Y, IMAI M: Effects of dichloroacetate in three patients with ME-LAS. Neurolology (1998) 50:531–534.
   PubMed Web of Science ®Google Scholar
• DESTAFANO N, MATTHEWS PM, FORD B. GENGE A, KASRPATI G, ARNOLD DL: Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurolology (1995) 45:1193–1198.
   Google Scholar
• STACPOOLE PW, BARNES CL, HURBANIS MD, CANNON SL, KERR DS: Treatment of congenital lactic acidosis with dichloroacetate. Arch. Dis. Child. (1997) 77:535–541.
   PubMed Web of Science ®Google Scholar
• KURODA Y, ITOMNAITO E, YOKOTA I et al.: Concomi-tant administration of sodium dichloroacetate and vitamin B1 for lactic acidemia in children with MELAS syndrome. J. Pediatr. (1997) 131:450–452.
   Google Scholar
• TOTH PP, EL-SHANTI H, EIVINS S, RHEA WJ, KLEIN JM: Transient improvement of congenital lactic acidosis in a male infant with pyruvate decarboxylase deficiency treated with dichloroacetate. j Pediatr. (1993) 123:427–430.
   PubMed Web of Science ®Google Scholar
• MOORE GW, SWIFT LL, RABINOWITZ D, CROFFORD OB, OATES IA, STACPOOLE PW: Reduction of serum choles-terol in two patients with homozygous familial hyper-cholesterolemia by dichloroacetate. Atherosclerosis (1979) 33:285–293.
   PubMed Web of Science ®Google Scholar
• HAAS R: Experience using oral DCA in four children with congenital lactic acidosis. Personal communication.
   Google Scholar
• KURLEMANN G, PAETZKE I, M'LLER H et al.: Therapy of complex I deficiency: peripheral neuropathy during dichloroacetate therapy. Eur. j Pediatr. (1995) 154:928–932.
   Google Scholar
• LANE JR, WILLIAMS PJ, TURKEL CC, WANG TC: Pharma-cokinetic (PK) model of serum and cerebral spinal fluid (CSF) CPC-211 (sodium dichloroacetate) concen-trations in patients with traumatic brain injury (TB!). Crit. Care Med. (1998) 28(Suppl.):A102.
   Google Scholar
• GRAHAM GD, BARKER PB, BROOKS et al.: International society of magnetic resonance spectroscopy. Philadel-phia, PA, USA (May 24–28 1999) (In Press).
   Google Scholar